• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

MicroRNA-10b调控乳腺癌细胞生长增殖与凋亡的研究

顾忆, 李小曼, 郑禄枫, 杨珏, 奚涛

顾忆, 李小曼, 郑禄枫, 杨珏, 奚涛. MicroRNA-10b调控乳腺癌细胞生长增殖与凋亡的研究[J]. 中国药科大学学报, 2015, 46(2): 242-249. DOI: 10.11665/j.issn.1000-5048.20150218
引用本文: 顾忆, 李小曼, 郑禄枫, 杨珏, 奚涛. MicroRNA-10b调控乳腺癌细胞生长增殖与凋亡的研究[J]. 中国药科大学学报, 2015, 46(2): 242-249. DOI: 10.11665/j.issn.1000-5048.20150218
GU Yi, LI Xiaoman, ZHENG Lufeng, YANG Jue, XI Tao. MicroRNA-10b regulates proliferation, cell cycle and apoptosis in human breast cancer cells[J]. Journal of China Pharmaceutical University, 2015, 46(2): 242-249. DOI: 10.11665/j.issn.1000-5048.20150218
Citation: GU Yi, LI Xiaoman, ZHENG Lufeng, YANG Jue, XI Tao. MicroRNA-10b regulates proliferation, cell cycle and apoptosis in human breast cancer cells[J]. Journal of China Pharmaceutical University, 2015, 46(2): 242-249. DOI: 10.11665/j.issn.1000-5048.20150218

MicroRNA-10b调控乳腺癌细胞生长增殖与凋亡的研究

MicroRNA-10b regulates proliferation, cell cycle and apoptosis in human breast cancer cells

  • 摘要: 研究MicroRNA-10b(miR-10b)对乳腺癌细胞MCF-7、MDA-MB-231的生长增殖和凋亡的调控作用。采用能模拟内源miR-10b的miR-10b模拟物以及能特异靶向敲除内源miR-10b的miR-10b抑制剂分别转染乳腺癌细胞MCF-7和MDA-MB-231。RT-PCR测定转染后细胞中miR-10b的表达水平,MTT检测miR-10b对细胞增殖活力的影响,流式细胞仪检测miR-10b对细胞周期和凋亡的影响。生物信息学软件预测miR-10b潜在的靶基因,3′UTR荧光素酶报告法验证其靶向性,Western blot检测caspase-3、P21的蛋白表达水平。研究证实,miR-10b模拟物上调乳腺癌中miR-10b的表达水平,与对照组相比,细胞增殖能力提高,细胞周期加速,细胞凋亡率降低;反之miR-10b抑制剂能显著下调miR-10b的表达,与对照组相比,细胞增殖能力降低,细胞周期阻滞,细胞凋亡率上调。初步探讨miR-10b的作用机制可能是通过靶向作用于TP53INP1,抑制细胞周期与凋亡关键蛋白caspase-3、P21的表达水平,从而促进乳腺癌的发生发展。
    Abstract: To investigate the effects of miRNA-10b(miR-10b)on breast cancer proliferation and apoptosis in MCF-7 and MDA-MB-231, the miR-10b mimics used to increase the endogenous expression of miR-10b, and miR-10b inhibitor used to decrease the endogenous expression of miR-10b, were stably transfected into MCF-7 and MDA-MB-231 breast cancer cells. The expression level of miR-10b was determined by real-time PCR. The effects of miR-10b on proliferation were evaluated by MTT assay, while cell cycle assay and the apoptosis rate were measured by flow cytometry. Bioinformatic software was used to predict the potential targets of miR-10b, and 3′UTR luciferase reporter and qRT-PCR assay were used to verify a direct target of miR-10b. The expression levels of caspase-3 and p21 protein were measured by Western blot. Results confirmed that over-expression of miR-10b could promote the proliferation of breast cancer cells and inhibit the apoptosis by up-regulating the endogenous miR-10b, while the miR-10b inhibitor could restrain the proliferation of breast cancer cells and increase the apoptosis by reducing the endogenous miR-10b. In conclusion, miR-10b could negatively regulate the expression of caspase-3 and p21 by targeting TP53INP1, hence highlighting its potential as an oncogene in breast cancer cells.
  • [1] Downs-Holmes C,SilvermanP.Breast cancer:overview&updates[J].Nurse Pract,2011,36(12):20-26.
    [2] Singer A,TresleyJ,Velazquez-Vega J,et al.Unusual aggressive breast cancer:metastatic malignant phyllodes tumor[J].J Radiol Case Rep,2013,7(3):24-37.
    [3] Liu J,Zheng M,Tang YL,et al.MicroRNAs,an active and versatile group in cancers[J].Int J Oral Sci,2011,3(4):165-175.
    [4] Andorfer CA,Necela BM,Thompson EA,et al.MicroRNA signatures:clinical biomarkers for the diagnosis and treatment of breast cancer[J].Trends Mol Med,2011,17(6):313-319.
    [5] Ladeiro Y, Couchy G. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene tumor suppressor gene mutations[J].Hepatology,2008,47(15):1955-1963.
    [6] Takashi S,Masamitsu N,Takeshi K,et al.MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors uPAR and RhoC[J].Int J Cancer,2009,125(12):1407-1413.
    [7] Garzon R,Garofalo M.Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin[J].Proc Nat Acad Sci U S A,2008,105(10):3945-3950.
    [8] Ma L,Teruya-Feldstein J,Weinberg RA.Tumour invasion and metastasis initiated by microRNA-10b in breast cancer[J].Nature,2007,449(7163):682-688.
    [9] Okamura S, Arakawa H, Tanaka T, et al. p53DINP1, a p53-inducible gene,regulates p53-dependent apoptosis[J].Mol Cell,2001,8(1):85-94.
    [10] Tomasini R,Samir AA,Carrier A,et al.TP53INP1s and homeodomain-interacting protein kinase-2(HIPK2)are partners in regulating p53 activity[J].J Biol Chem,2003,278(39):37722-37729.
    [11] Le MT,Shyh-Chang N,Khaw SL,et al.Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs[J].PLoS Genet,2011,7(9):1-11.
    [12] Ito Y,Motoo Y,Yoshida H,et al.Decreased expression of tumor protein p53-induced nuclear protein 1(TP53INP1)in breast carcinoma[J].Anticancer Res,2006,26(6B):4391-4395.
    [13] Jiang PH,Motoo Y,Garcia S,et al.Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer[J].World J Gastroenterol,2006,12(5):691-696.
    [14] Gironella M,Seux M,Xie MJ,et al.Tumor protein p53-induced nuclear protein 1 expression is repressed by miR-155,and its restoration inhibits pancreatic tumor development[J].Proc Natl Acad Sci U S A,2007,104(41):16170-16175.
    [15] Bartel DP.MicroRNAs:target recognition and regulatory functions[J].Cell,2009,123(2):215-233.
    [16] Zhang B,Pan X,Cobb GP.MicroRNAs as oncogenes and tumor suppressors[J].Dev Biol,2007,302(28):1-12.
    [17] Negrini M,Calin GA.Breast cancer metastasis:a microRNA story[J].Breast Cancer Res,2008,10(2):303-307.
    [18] Yananadala V,Negoro H,Denker BM.Heterotrimeric G proteins and apoptosis:intersecting signaling pathways leading to context dependent phenotypes[J].Curr Mol Med,2009,9(5):527-545.
    [19] Seillier M,Peuget S,Gayet O,et al.TP53INP1,a tumor suppressor,interacts with LC3 and ATG8-family proteins through the LG3-interacting region(LIR)and promotes autophagy-dependent cell death[J].Cell Death Differ,2012,19(9):1525-1535.
    [20] Yeung ML,Yasunaga J,Bennasser Y,et al.Roles for micro RNAs,miR-93 and miR-130b,and tumor protein 53 induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1[J].Cancer Res,2008,68(21):8976-8985.
    [21] Ma S,Tang KH,Chan YP,et al.miR-130b promotes CD133(+)liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1[J].Cell Stem Cell,2010,7(6):694-707.
    [22] Jiang F,Liu T,He Y,et al.MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo[J].BMC Cancer,2011,5(11):425-437.
    [23] Shibuya H,Linuma H,Shimada R,et al.Clinic opathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer[J].Oncology,2010,79(3/4):313-320.
    [24] Yamamoto Y, Yoshioka Y, Minoura K, et al. An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells[J].Mol Cancer,2011,10(1):135-151.
    [25] Salmena L,Poliseno L,Tay Y,et al.A ceRNA hypothesis:the Rosetta Stone of a hidden RNA language[J]?Cell,2011,146(3):353-358.
    [26] Tay Y,Kats L,Salmena L,et al.Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs[J].Cell,2011,147(2):344-357.
    [27] Sumazin P,Yang X,Chiu HS,et al.An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma[J].Cell,2011,147(2):370-381.
计量
  • 文章访问数:  946
  • HTML全文浏览量:  5
  • PDF下载量:  1571
  • 被引次数: 0
出版历程
  • 刊出日期:  2015-04-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭